Caseware UK (AP4) 2023.0.135 2023.0.135 2023-12-312023-12-312022-07-01falseNo description of principal activity22falsetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 08399972 2022-07-01 2023-12-31 08399972 2023-12-31 08399972 2021-07-01 2022-06-30 08399972 2022-06-30 08399972 c:CompanySecretary1 2022-07-01 2023-12-31 08399972 c:Director1 2022-07-01 2023-12-31 08399972 c:Director2 2022-07-01 2023-12-31 08399972 c:Director2 2023-12-31 08399972 c:RegisteredOffice 2022-07-01 2023-12-31 08399972 d:Buildings d:LongLeaseholdAssets 2022-07-01 2023-12-31 08399972 d:Buildings d:LongLeaseholdAssets 2023-12-31 08399972 d:Buildings d:LongLeaseholdAssets 2022-06-30 08399972 d:OfficeEquipment 2022-07-01 2023-12-31 08399972 d:OfficeEquipment 2023-12-31 08399972 d:OfficeEquipment 2022-06-30 08399972 d:OfficeEquipment d:OwnedOrFreeholdAssets 2022-07-01 2023-12-31 08399972 d:ComputerEquipment 2022-07-01 2023-12-31 08399972 d:ComputerEquipment 2023-12-31 08399972 d:ComputerEquipment 2022-06-30 08399972 d:ComputerEquipment d:OwnedOrFreeholdAssets 2022-07-01 2023-12-31 08399972 d:OtherPropertyPlantEquipment 2022-07-01 2023-12-31 08399972 d:OtherPropertyPlantEquipment 2023-12-31 08399972 d:OtherPropertyPlantEquipment 2022-06-30 08399972 d:OtherPropertyPlantEquipment d:OwnedOrFreeholdAssets 2022-07-01 2023-12-31 08399972 d:OwnedOrFreeholdAssets 2022-07-01 2023-12-31 08399972 d:CurrentFinancialInstruments 2023-12-31 08399972 d:CurrentFinancialInstruments 2022-06-30 08399972 d:CurrentFinancialInstruments d:WithinOneYear 2023-12-31 08399972 d:CurrentFinancialInstruments d:WithinOneYear 2022-06-30 08399972 d:ShareCapital 2023-12-31 08399972 d:ShareCapital 2022-06-30 08399972 d:RetainedEarningsAccumulatedLosses 2023-12-31 08399972 d:RetainedEarningsAccumulatedLosses 2022-06-30 08399972 c:FRS102 2022-07-01 2023-12-31 08399972 c:AuditExempt-NoAccountantsReport 2022-07-01 2023-12-31 08399972 c:FullAccounts 2022-07-01 2023-12-31 08399972 c:PrivateLimitedCompanyLtd 2022-07-01 2023-12-31 08399972 6 2022-07-01 2023-12-31 08399972 e:PoundSterling 2022-07-01 2023-12-31 iso4217:GBP xbrli:pure
Company registration number: 08399972







UNAUDITED FINANCIAL STATEMENTS
FOR THE PERIOD ENDED
31 DECEMBER 2023


HCE MEDICAL GROUP LIMITED






































img6979.png                        

 


HCE MEDICAL GROUP LIMITED
 


 
COMPANY INFORMATION


Directors
R S Singh 
M J Miles (resigned 24 July 2023)




Company secretary
M J Miles



Registered number
08399972



Registered office
Blays Cottage
Blays Lane

Englefield Green

Egham

Surrey

TW20 0PB




Accountants
Menzies LLP
Chartered Accountants

1st Floor

Midas House

62 Goldsworth Road

Woking

Surrey

GU21 6LQ





 


HCE MEDICAL GROUP LIMITED
 



CONTENTS



Page
Statement of financial position
1 - 2
Company statement of financial position
3 - 2
Notes to the financial statements
3 - 6


 


HCE MEDICAL GROUP LIMITED
REGISTERED NUMBER:08399972



STATEMENT OF FINANCIAL POSITION
AS AT 31 DECEMBER 2023

31 December
30 June
2023
2022
Note
£
£

Fixed assets
  

Tangible assets
 5 
18,530
51,258

Investments
 6 
2
301,449

  
18,532
352,707

Current assets
  

Debtors: amounts falling due within one year
 7 
1,041,593
19,343

Cash at bank and in hand
  
4,506
9,003

  
1,046,099
28,346

Creditors: amounts falling due within one year
 8 
(839,235)
(839,536)

Net current assets/(liabilities)
  
 
 
206,864
 
 
(811,190)

Total assets less current liabilities
  
225,396
(458,483)

  

Net assets/(liabilities)
  
225,396
(458,483)


Capital and reserves
  

Called up share capital 
  
2,300
2,300

Profit and loss account
  
223,096
(460,783)

  
225,396
(458,483)


Page 1

 


HCE MEDICAL GROUP LIMITED
REGISTERED NUMBER:08399972


    
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 31 DECEMBER 2023

The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the period in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 23 August 2024.




................................................
R S Singh
Director

The notes on pages 3 to 6 form part of these financial statements.

Page 2

 


HCE MEDICAL GROUP LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2023

1.


General information

HCE Medical Group Limited is a private company limited by shares incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of it's registered office is disclosed on the company information page. The group's principal place of business is the same as its registered office.
The Company extended its year end from 30 June 2023 to 31 December 2023 as part of the company restructuring plans. These financial statements present the activity of the company for the 18 month period ended 31 December 2023 which are not entirely comparable to the previous 12 months ended 30 June 2023.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives as follows;

Depreciation is provided on the following basis:

Leasehold Improvements
-
over remaining length of lease
Office equipment
-
18% reducing balance
Computer equipment
-
18% reducing balance
Software costs
-
over 4 years

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.3

Valuation of investments

Investments in subsidiaries are measured at cost less accumulated impairment.

 
2.4

Financial instruments

The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.

Page 3

 


HCE MEDICAL GROUP LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2023

3.


Employees

The average monthly number of employees, including directors, during the period was 2 (2022 - 2).


4.


Exceptional items


The exceptional costs reflected in the year ended 30 June 2021 represents trade debtors that are considered irrecoverable.


5.


Tangible fixed assets







Leasehold Improvements
Office equipment
Computer equipment
Software
Total

£
£
£
£
£



Cost or valuation


At 1 July 2022
6,400
14,550
19,480
59,638
100,068


Additions
-
-
2,995
-
2,995



At 31 December 2023

6,400
14,550
22,475
59,638
103,063



Depreciation


At 1 July 2022
2,560
6,474
9,957
29,819
48,810


Charge for the period on owned assets
1,920
2,181
3,380
28,242
35,723



At 31 December 2023

4,480
8,655
13,337
58,061
84,533



Net book value



At 31 December 2023
1,920
5,895
9,138
1,577
18,530



At 30 June 2022
3,840
8,076
9,523
29,819
51,258

Page 4

 


HCE MEDICAL GROUP LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2023

6.


Fixed asset investments








Investments in subsidiary companies

£



Cost or valuation


At 1 July 2022
301,449


Disposals
(301,447)



At 31 December 2023
2




Page 5

 


HCE MEDICAL GROUP LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2023

7.


Debtors

31 December
30 June
2023
2022
£
£


Amounts owed by group undertakings
443,761
5,699

Other debtors
593,797
5,553

Prepayments and accrued income
4,035
8,091

1,041,593
19,343



8.


Creditors: Amounts falling due within one year

31 December
30 June
2023
2022
£
£

Trade creditors
34,272
5,873

Amounts owed to group undertakings
-
822,749

Other creditors
801,950
7,901

Accruals and deferred income
3,013
3,013

839,235
839,536



9.


Commitments under operating leases

At 31 December 2023 the Company had total future minimum lease payments due under non-cancellable operating leases of £24,875 (2022: £47,375).


10.


Related party transactions


Brought forward 1.7.2022
Advances
Repaid
Carried forward 31.12.2023
£
£
£
£

Directors loan account
(7,901)
133,384
(58,526)
66,957
(7,901)
133,384
(58,526)
66,957

Interest of 2.25% has been applied in the year.

Page 6